[PAR-25-362] Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
National Institutes of Health
Deadline
5 November 2028
Maximum amount
$400,000
Description
Titolo: Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) Numero dell'opportunità: PAR-25-362 Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: National Institutes of Health — Department of Health and Human Services Tipo di finanziamento: Grant Categoria: Health; Income Security and Social Services Programma (ALN): 93.865 Child Health and Human Development Extramural Research Pubblicato il: 2024-12-30 Scadenza per le domande: 2028-11-05 Importo massimo per progetto: 400,000 USD Cofinanziamento richiesto: no Chi può fare domanda: State governments; Public and State controlled institutions of higher education; County governments; Private institutions of higher education; Independent school districts; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); City or township governments; Small businesses; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Special district governments Altre condizioni di eleggibilità: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. Descrizione: The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity. Annuncio completo: http://grants.nih.gov/grants/guide/pa-files/PAR-25-362.html Contatto: [email protected]
Sectors
Want to know if this call is right for you?
Sign up free: Bandolo compares the call with your profile, company or professional, and tells you how well it fits.
Sign up free